Accolade Inc. (NASDAQ:ACCD) shares traded -5.76% lower at $9.00 on Wall Street last session.
In accordance with the data, 16 analysts cover Accolade Inc. (NASDAQ:ACCD). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $15.00 and a low of $10.00, we find $13.00. Given the previous closing price of $9.55, this indicates a potential upside of 36.13 percent. ACCD stock price is now 3.91% away from the 50-day moving average and -8.84% away from the 200-day moving average. The market capitalization of the company currently stands at $642.24M.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our
5 Best Growth Stocks To Own For 2023.
Sponsored
It has been rated a hold by 7 analysts and a buy by 9. Brokers who have rated the stock have averaged $12.73 as their price target over the next twelve months.
On September 07, 2022, Truist recently initiated its ‘Buy’ rating on the stock quoting a target price of $15, while ‘DA Davidson’ rates the stock as ‘Buy’.
In other news, Barnes Stephen H., Chief Financial Officer sold 74 shares of the company’s stock on Jan 04. The stock was sold for $563 at an average price of $7.61. Upon completion of the transaction, the Chief Financial Officer now directly owns 122,960 shares in the company, valued at $1.11 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 19, Chief Executive Officer SINGH RAJEEV sold 230 shares of the business’s stock. A total of $1,939 was realized by selling the stock at an average price of $8.43. This leaves the insider owning 153,209 shares of the company worth $1.38 million. Insiders disposed of 5,818 shares of company stock worth roughly $52362.0 over the past 1 year. A total of 0.90% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in ACCD stock. A new stake in Accolade Inc. shares was purchased by POINT72 ASSET MANAGEMENT, L.P. during the first quarter worth $5,021,000. WOODLINE PARTNERS LP invested $2,689,000 in shares of ACCD during the first quarter. In the first quarter, DIMENSIONAL FUND ADVISORS LP acquired a new stake in Accolade Inc. valued at approximately $2,030,000. ADVISORY RESEARCH INC acquired a new stake in ACCD for approximately $651,000. BNP PARIBAS ARBITRAGE, SNC purchased a new stake in ACCD valued at around $577,000 in the second quarter. In total, there are 233 active investors with 82.70% ownership of the company’s stock.
Accolade Inc. (NASDAQ: ACCD) opened at $9.56 on Wednesday. During the past 12 months, Accolade Inc. has had a low of $4.61 and a high of $24.95. As of last week, the company has a debt-to-equity ratio of 0.56, a current ratio of 3.30, and a quick ratio of 3.30. The fifty day moving average price for ACCD is $8.66 and a two-hundred day moving average price translates $9.87 for the stock.
The latest earnings results from Accolade Inc. (NASDAQ: ACCD) was released for Aug, 2022. According to the Health Information Services Company, earnings per share came in at -$0.66, beating analysts’ expectations of -$0.72 by 0.06. This compares to $0.31 EPS in the same period last year. The company reported revenue of $90.95 million for the quarter, compared to $83.45 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 8.98 percent. For the current quarter, analysts expect ACCD to generate $87.54M in revenue.
Accolade Inc.(ACCD) Company Profile
Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees’ families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
